Skip to main content
. 2011 May;55(5):1975–1981. doi: 10.1128/AAC.01627-10

Fig. 3.

Fig. 3.

Pharmacokinetics after i.v. and p.o. dosing of CD1 mice. (A) Concentration in whole blood after i.v. dosing (1 mg/kg) of SfA, SfB, SfC, and SfD. (B) Concentration in whole blood after p.o. dosing (10 mg/kg) of SfA, SfB, SfC, and SfD. The error bars indicate standard deviations.